Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

790
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

826
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
826
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

805
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

952
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
952
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

645
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
645
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

2.1K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Respiratory Toxicity of Aged Paint Particles on a Building Exterior Wall.

Environmental toxicology·2026
Same author

<i>Zingiber officinale</i> Leaf Subcritical Water Extract Suppresses Adipogenesis and Lipogenesis in 3T3-L1 Adipocytes via the AMPK-SREBP-1c Signaling Pathway.

International journal of medical sciences·2026
Same author

Pulmonary toxicity of micro- and nano polyethylene particles following intratracheal instillation in rats.

Particle and fibre toxicology·2026
Same author

Biodistribution and toxicity of inhaled nickel oxide nanoparticles: Potential application to realistic exposure.

Toxicology and applied pharmacology·2026
Same author

Fucoidan P Alleviates Sarcopenic Obesity by Regulating Muscle Protein and Energy Metabolism.

International journal of biological sciences·2026
Same author

Combined short- and mid-latency SSEP amplitudes for early prediction of favorable neurological recovery after cardiac arrest.

Resuscitation·2026

Related Experiment Video

Updated: May 1, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

4.4K

Carbon monoxide-induced cardiomyopathy.

Yoon-Seok Jung1, Ji-Sook Lee, Young-Gi Min

  • 1Department of Emergency Medicine, Ajou University School of Medicine.

Circulation Journal : Official Journal of the Japanese Circulation Society
|April 8, 2014
PubMed
Summary

Carbon monoxide (CO) poisoning can cause cardiomyopathy (CMP), a heart muscle condition. While 3.04% of patients developed CO-induced CMP, most recovered fully, indicating a favorable prognosis.

More Related Videos

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

3.3K
A Hypoxia-Reoxygenation Injury Model in Self-Assembling Human Cardioids
10:41

A Hypoxia-Reoxygenation Injury Model in Self-Assembling Human Cardioids

Published on: March 17, 2026

203

Related Experiment Videos

Last Updated: May 1, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

4.4K
Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

3.3K
A Hypoxia-Reoxygenation Injury Model in Self-Assembling Human Cardioids
10:41

A Hypoxia-Reoxygenation Injury Model in Self-Assembling Human Cardioids

Published on: March 17, 2026

203

Area of Science:

  • Cardiology
  • Toxicology
  • Emergency Medicine

Background:

  • Cardiac toxicity is a known complication of acute carbon monoxide (CO) poisoning.
  • However, CO-induced cardiomyopathy (CMP) has not been established as a distinct clinical entity.
  • This study investigates the epidemiology, clinical features, and prognosis of CO-induced CMP.

Purpose of the Study:

  • To determine the incidence of CO-induced cardiomyopathy in patients with acute CO poisoning.
  • To describe the clinical characteristics of patients with CO-induced CMP.
  • To evaluate the prognosis of CO-induced CMP.

Main Methods:

  • A retrospective study of 626 patients diagnosed with acute CO poisoning.
  • Initial echocardiography to assess cardiac function and wall motion.
  • Follow-up echocardiography within 12 days to evaluate recovery.

Main Results:

  • CO-induced CMP was identified in 3.04% (19/626) of patients.
  • Echocardiography revealed global or regional hypokinesia/akinesia, with reduced ejection fraction (EF) in 14 patients.
  • Follow-up echocardiography showed normalization of cardiac wall motion and EF (≥50%) in most patients.

Conclusions:

  • CO-induced CMP is a recognized complication of acute CO poisoning with a generally favorable prognosis.
  • Myocardial stunning, likely due to a catecholamine surge, is implicated in the development of CO-induced CMP.
  • The findings suggest similarities between CO-induced CMP and takotsubo cardiomyopathy.